TD Cowen upgrades Waters stock rating to buy, raises price target to $475
What it means
- What to watch: $WAT was upgraded; the new price target against where shares already trade is the gap that tells you how bold the call is.
- How the stock is trading: $WAT +2.12% in the latest session.
- Timing: It came out pre-market, so the next session was the first that could react.
Where the stock stands
$WAT last changed hands at $478.47, +2.12% on the session, 0.8% below its 52-week high of $482.28 and 69% above its low of $282.77 — within a tenth of its 52-week high. Over the year it has ranged 71% from low to high: a wide band — moves of several percent in a week come with the territory. These are latest-session quotes, not live prices — the live tape is on the $WAT page.
How much coverage it is getting
This is the only story Wook has logged on $WAT in the last 30 days — a quiet name that just got a headline. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$WAT earnings in 6 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
For the receipts, the $WAT page has the full chart, the filings and the valuation model these figures come from. Comparing how two or three outlets frame the same story is the fastest way to separate the facts from the angle. Wook AI, above, can pull live figures and run the numbers on request — how far $WAT is from its high, or how this week's coverage compares.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. It reads bullish at medium severity because of “upgrade” in the wording, with nothing on the bearish side to offset it. It was matched to $WAT. It carried $475, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 5, 2026. $WAT has moved +19.62% ($400.00 to $478.47). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.